Application of the Improving Pediatric Sepsis Outcomes Definition for Pediatric Sepsis to Nationally Representative

Sriram Ramgopal1,2, Mark D Adler1,2, Christopher M Horvat3,4,5,6

  • 1Department of Pediatrics (Emergency Medicine), Northwestern University Feinberg School of Medicine, Chicago, Ill.

Insights

Pediatric sepsis case estimates vary significantly based on the criteria used. Modified Improving Pediatric Sepsis Outcomes (IPSO) criteria identified more severe cases than severe sepsis criteria.

Area of Science:

  • Pediatric Emergency Medicine
  • Critical Care
  • Health Services Research

Background:

  • Pediatric sepsis is a life-threatening condition requiring timely diagnosis and treatment.
  • Accurate identification of pediatric sepsis cases in administrative datasets is crucial for research and quality improvement.

Purpose of the Study:

  • To compare encounter estimates and patient demographics for pediatric sepsis using modified Improving Pediatric Sepsis Outcomes (IPSO) criteria versus other established criteria.
  • To evaluate the characteristics of pediatric sepsis cohorts identified through different ascertainment methods in administrative data.

Main Methods:

  • Analysis of the National Hospital Ambulatory Medical Care Survey (2003-2018) data.
  • Comparison of three pediatric sepsis criteria: modified IPSO, explicit diagnostic codes, and implicit severe sepsis.
  • Reporting of encounter estimates, demographics, and treatments for each cohort.

Main Results:

  • Modified IPSO criteria yielded the highest yearly encounter estimate (116,200), followed by severe sepsis (56,000) and explicit criteria (27,900).
  • The modified IPSO cohort showed high rates of antibiotics, IV fluids, and blood cultures. The explicit criteria cohort had high admission rates but lower diagnostic test utilization.
  • The severe sepsis definition identified the fewest cases and had the lowest rates of blood cultures and admissions.

Conclusions:

  • Different criteria for identifying pediatric sepsis in administrative data result in substantially different encounter estimates and cohort characteristics.
  • The modified IPSO criteria identified a higher acuity population compared to the severe sepsis definition, but lower acuity than the explicit criteria cohort.

Related Concept Videos

Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
11
Drug Dosing: Infants and Children01:29

Drug Dosing: Infants and Children

Pediatric patient dosages diverge from adults due to disparities in body surface area, total body water, and extracellular fluid per kilogram of body weight. The dosing regimen considers the variations in pharmacokinetics and pharmacology across distinct age groups, encompassing preterm newborns, infants, young children, older children, and adolescents. Calculation of pediatric patient doses is predicated on determining body surface area, which exhibits a superior correlation with the child's...
21
Healthcare Associated Infections II: Preventive Measures01:22

Healthcare Associated Infections II: Preventive Measures

Essential infection prevention measures are based on the knowledge of the infection chain, the modes of transmission in healthcare settings, and the use of the best practices in all healthcare settings. Compulsory public reporting of healthcare-associated infection rates is needed to allow individuals and the community to make informed choices regarding selecting a healthcare facility.
The best practices for preventing healthcare-associated infections include hand hygiene, patient risk...
3.1K
Pharmacokinetics in Pediatric Patients: Drug Distribution01:17

Pharmacokinetics in Pediatric Patients: Drug Distribution

Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight,...
10
Acute Pyelonephritis II: Diagnostic Studies and Management01:28

Acute Pyelonephritis II: Diagnostic Studies and Management

Introduction:For diagnosing acute pyelonephritis, a comprehensive patient history is collected to identify symptoms such as dysuria, frequent or urgent urination, flank pain, or costovertebral angle (CVA) tenderness that may suggest a kidney infection.Physical ExaminationDuring the physical examination, CVA tenderness is assessed. This involves gentle percussion over the costovertebral angle, where tenderness often indicates a kidney infection.Diagnostic TestsUrinalysis: Used to identify white...
65
Pharmacokinetics in Pediatric Patients: Drug Metabolism01:24

Pharmacokinetics in Pediatric Patients: Drug Metabolism

In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses...
17